Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis

M. H. Imam, E. W. Thackeray, K. D. Lindor

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Aim Current guidelines recommend annual surveillance for colorectal cancer (CRC) in all patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC). The aim of our study was to validate the need for annual surveillance for colon neoplasia in patients ≤45 of age with a combined diagnosis of PSC and IBD. Method We identified patients, ≤45years of age with a combined diagnosis of PSC and IBD, who were seen at the Mayo Clinic between 1995 and 2010. We then reviewed the medical records of the patients who developed colonic neoplasia defined as cancer, high-grade dysplasia (HGD) or dysplasia-associated lesion or mass (DALM). Results In the population of 784 patients ≤45years of age with a combined diagnosis of PSC and IBD, 10 (1.3%) of 784 developed colonic neoplasia during the follow-up period. Seven patients had colon cancer, one had HGD and two had a DALM. Conclusion Colonic neoplasia is uncommon in young patients (≤45years of age) with a combined diagnosis of PSC and IBD. We suggest delaying surveillance in young patients and propose that studies should be carried out to clarify the cost-effectiveness of annual or biannual surveillance colonoscopies according to patient age.

Original languageEnglish (US)
Pages (from-to)198-203
Number of pages6
JournalColorectal Disease
Volume15
Issue number2
DOIs
StatePublished - Feb 1 2013
Externally publishedYes

Keywords

  • Colorectal cancer
  • Inflammatory bowel disease
  • Primary sclerosing cholangitis
  • Surveillance

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis'. Together they form a unique fingerprint.

  • Cite this